Literature DB >> 30682456

Nanoallergen platform for detection of platin drug allergies.

Peter E Deak1, Baksun Kim1, Ather Adnan2, Marina Labella2, Leticia De Las Vecillas3, Mariana Castells2, Basar Bilgicer4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30682456      PMCID: PMC6608568          DOI: 10.1016/j.jaci.2019.01.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.

Authors:  Johnson T Wong; Morris Ling; Sarita Patil; Aleena Banerji; Aidan Long
Journal:  J Allergy Clin Immunol Pract       Date:  2013-11-01

2.  Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.

Authors:  Joana Caiado; Lennart Venemalm; Maria Conceição Pereira-Santos; Luis Costa; Manuel Pereira Barbosa; Mariana Castells
Journal:  J Allergy Clin Immunol Pract       Date:  2013-08-30

Review 3.  Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.

Authors:  Joana Caiado; Mariana Castells
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

4.  Liposomes as carriers for allergy immunotherapy.

Authors:  C Audera; J Ramírez; E Soler; J Carreira
Journal:  Clin Exp Allergy       Date:  1991-01       Impact factor: 5.018

5.  Effects of amine ligand bulk and hydrogen bonding on the rate of reaction of platinum(II) diamine complexes with key nucleotide and amino acid residues.

Authors:  Rebecca D Sandlin; Celia J Whelan; M Samuel Bradley; Kevin M Williams
Journal:  Inorganica Chim Acta       Date:  2012-05-19       Impact factor: 2.545

6.  Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulation.

Authors:  Peter E Deak; Maura R Vrabel; Vincenzo J Pizzuti; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-13

7.  Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.

Authors:  G S Ladics; J H M van Bilsen; H M H Brouwer; L Vogel; S Vieths; L M J Knippels
Journal:  Regul Toxicol Pharmacol       Date:  2008-04-27       Impact factor: 3.271

8.  Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.

Authors:  Mariana C Castells; Nichole M Tennant; David E Sloane; F Ida Hsu; Nora A Barrett; David I Hong; Tanya M Laidlaw; Henry J Legere; Samridhi N Nallamshetty; Ross I Palis; Jayanti J Rao; Suzanne T Berlin; Susana M Campos; Ursula A Matulonis
Journal:  J Allergy Clin Immunol       Date:  2008-05-27       Impact factor: 10.793

9.  Hypersensitivity to oxaliplatin: clinical features and risk factors.

Authors:  Marie Parel; Florence Ranchon; Audrey Nosbaum; Benoit You; Nicolas Vantard; Vérane Schwiertz; Chloé Gourc; Noémie Gauthier; Marie-Gabrielle Guedat; Sophie He; Eléna Kiouris; Céline Alloux; Thierry Vial; Véronique Trillet-Lenoir; Gilles Freyer; Frédéric Berard; Catherine Rioufol
Journal:  BMC Pharmacol Toxicol       Date:  2014-01-13       Impact factor: 2.483

  9 in total
  3 in total

1.  Soluble FcεRI, IgE, and tryptase as potential biomarkers of rapid desensitizations for platin IgE sensitized cancer patients.

Authors:  Sherezade Moñino-Romero; Leticia de Las Vecillas; Leila A Alenazy; Marina Labella; Zsolt Szépfalusi; Edda Fiebiger; Mariana C Castells
Journal:  J Allergy Clin Immunol Pract       Date:  2020-02-04

Review 2.  Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines.

Authors:  Francisca Palomares; Juan L Paris; Marina Labella; Inmaculada Doña; Cristobalina Mayorga; María José Torres
Journal:  Allergy       Date:  2022-08-01       Impact factor: 14.710

Review 3.  Advances and novel developments in molecular allergology.

Authors:  Öykü Üzülmez; Tanja Kalic; Heimo Breiteneder
Journal:  Allergy       Date:  2020-09-22       Impact factor: 14.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.